A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies, found outside ...

President Trump is expected to unveil plans to lower healthcare costs, which could significantly impact the pharmaceutical industry. Additionally, Pfizer's (PFE) entry into the weight-loss drug space, ...

UNC senior Reese Brantmeier defeated Cal's Berta Passola Folch to win the NCAA Women's Singles Championship in Orlando Sunday ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short ...

Tom Norton is Newsweek's Fact Check reporter, based in London. His focus is reporting on misinformation and misleading ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

The Dow Jones Industrial Average added 248 points, and the S&P 500 index gained over 30 points. The tech-heavy Nasdaq ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...